DMA4-H228
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
DMA4-H228 is an ionizable cationic lipidoid employed in creating lipid nanoparticles (LNPs) for mRNA delivery in vivo. These LNPs, enriched with DMA4-H228, specifically accumulate in antigen-presenting cells within the mouse spleen. When encapsulating mRNA for ovalbumin, these LNPs activate splenic antigen-presenting cells and elevate serum IFN-α levels in mice. Additionally, in a B16/F10-OVA murine melanoma model, such LNPs reduce tumor volume, increase intratumoral CD8+ T cells, and elevate serum anti-ovalbumin IgG titers.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1098336-01 0.02 mg (E-Coli)
Recombinant Salmonella enteritidis PT4 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD)
Sign In for Pricing
View Details MBS1098336-02 0.02 mg (Yeast)
Recombinant Salmonella enteritidis PT4 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD)
Sign In for Pricing
View Details MBS1098336-03 0.1 mg (E-Coli)
Recombinant Salmonella enteritidis PT4 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD)
Sign In for Pricing
View Details MBS1098336-04 0.1 mg (Yeast)
Recombinant Salmonella enteritidis PT4 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD)
Sign In for Pricing
View Details MBS1098336-05 0.02 mg (Baculovirus)
Recombinant Salmonella enteritidis PT4 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD)
Sign In for Pricing
View Details MBS1098336-06 0.02 mg (Mammalian-Cell)
Recombinant Salmonella enteritidis PT4 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD)
Sign In for Pricing
View Details